Enlivex Ltd. (ENLV)
0.2599
-0.02
(-6.17%)
USD |
NASDAQ |
Oct 09, 16:00
0.255
0.00 (0.00%)
After-Hours: 16:14
Enlivex Shareholders Equity (Quarterly) : 3.898B for June 30, 2026
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 3.898B |
| December 31, 2025 | 1.935B |
| September 30, 2025 | 17.48M |
| June 30, 2025 | 19.05M |
| March 31, 2025 | 20.63M |
| December 31, 2024 | 23.59M |
| September 30, 2024 | 26.59M |
| June 30, 2024 | 28.56M |
| March 31, 2024 | 26.85M |
| December 31, 2023 | 30.08M |
| September 30, 2023 | 38.78M |
| June 30, 2023 | 44.34M |
| March 31, 2023 | 50.57M |
| December 31, 2022 | 56.84M |
| September 30, 2022 | 63.27M |
| June 30, 2022 | 68.49M |
| March 31, 2022 | 77.65M |
| December 31, 2021 | 85.04M |
| September 30, 2021 | 88.08M |
| June 30, 2021 | 90.21M |
| March 31, 2021 | 90.60M |
| December 31, 2020 | 35.49M |
| September 30, 2020 | 28.50M |
| June 30, 2020 | 30.19M |
| March 31, 2020 | 32.06M |
| Date | Value |
|---|---|
| December 31, 2019 | 11.28M |
| September 30, 2019 | 13.78M |
| June 30, 2019 | 15.36M |
| March 31, 2019 | 13.46M |
| December 31, 2018 | |
| September 30, 2018 | |
| June 30, 2018 | |
| March 31, 2018 | |
| December 31, 2017 | 3.162M |
| September 30, 2017 | 3.746M |
| June 30, 2017 | 4.722M |
| March 31, 2017 | 6.268M |
| December 31, 2016 | 8.699M |
| September 30, 2016 | 11.37M |
| June 30, 2016 | 15.49M |
| March 31, 2016 | 20.18M |
| December 31, 2015 | 17.93M |
| September 30, 2015 | 22.11M |
| June 30, 2015 | 25.13M |
| March 31, 2015 | 28.10M |
| December 31, 2014 | 30.67M |
| September 30, 2014 | 33.39M |
| June 30, 2014 | 3.801M |
| March 31, 2014 | |
| December 31, 2013 | 0.175M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Polyrizon Ltd. | -- |
| NovelStem International Corp. | -2.032M |
| Brainstorm Cell Therapeutics, Inc. | -11.60M |
| Summit Therapeutics, Inc. | 629.98M |
| PeptiDream Inc. | 298.75M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 4.900B |
| Total Liabilities (Quarterly) | 1.002B |
| Debt to Equity Ratio | 0.0045 |
| Current Ratio | 119.39 |
| Net Debt Paydown Yield | -2.45% |